Search

Mingjie Zhang

from Trenton, NJ
Age ~47
Get Report
Also known as:
Ming Jie Zhang, Ming J Zhang, Zhang Mingie
Related to:
Zhang Cui, 49Juntong Zhang, 42
Connected to:
Aimei Zhang, 44Aining Zhang, 30Aiqing Zhang, 50Alexia Y Zhang, 36Amy X Zhang, 57Angelina Zhang, 54Ashley C Zhang, 60Baomin Zhang, 55Beilei Zhang, 45Carl Zhang, 33

Mingjie Zhang Phones & Addresses

  • Trenton, NJ
  • Stamford, CT
  • San Angelo, TX
  • Washington, DC
  • Greenbelt, MD
  • Santa Fe, NM

Publications

Us Patents

Subgenomic Replicons Of The Flavivirus Dengue

View page
US Patent:
7524508, Apr 28, 2009
Filed:
Sep 5, 2003
Appl. No.:
10/656721
Inventors:
Xiaowu Pang - Rockville MD, US
Andrew I. Dayton - Knoxville MD, US
Mingjie Zhang - Bethesda MD, US
Assignee:
The United states of America as represented by the Department of Health and Human Services - Washington DC
International Classification:
A61K 39/12
C12N 7/00
C12N 7/01
C12N 15/86
C12N 15/40
US Classification:
4242051, 4241991, 4242181, 4352351, 4353201, 536 2372
Abstract:
The present invention discloses the construction of dengue virus subgenomic replicons containing large deletions in the structural region (C-preM-E) of the genome, which replicons are useful as vaccines to protect against dengue virus infection.

Subgenomic Replicons Of The Flavivirus Dengue

View page
US Patent:
8048427, Nov 1, 2011
Filed:
Feb 27, 2009
Appl. No.:
12/394822
Inventors:
Xiaowu Pang - Rockville MD, US
Andrew I. Dayton - Knoxville MD, US
Mingjie Zhang - Bethesda MD, US
Assignee:
The United States of America as represented by the Secretary, Department of Health and Human Services - Washington DC
International Classification:
A61K 39/12
C12N 7/01
C12N 15/86
US Classification:
4241991, 4242051, 4242181, 4352351, 4353201
Abstract:
The present invention discloses the construction of dengue virus subgenomic replicons containing large deletions in the structural region (C-preM-E) of the genome, which replicons are useful as vaccines to protect against dengue virus infection.

Subgenomic Replicons Of The Flavivirus Dengue

View page
US Patent:
20120107358, May 3, 2012
Filed:
Sep 23, 2011
Appl. No.:
13/242036
Inventors:
Xiaowu Pang - Rockville MD, US
Andrew I. Dayton - Knoxville MD, US
Mingjie Zhang - Bethesda MD, US
Assignee:
The Government of the USA, as represented by the Secretary, Department of Health & Human Services - Bethesda MD
International Classification:
A61K 39/12
A61P 31/14
A61P 37/04
C07H 21/00
C12N 7/00
US Classification:
4242181, 536 2372, 4352351
Abstract:
The present invention discloses the construction of dengue virus subgenomic replicons containing large deletions in the structural region (C-preM-E) of the genome, which replicons are useful as vaccines to protect against dengue virus infection.

Subgenomic Replicons Of The Flavivirus Dengue

View page
US Patent:
20160243214, Aug 25, 2016
Filed:
Oct 26, 2015
Appl. No.:
14/923134
Inventors:
- Rockville MD, US
Andrew I. Dayton - Bethesda MD, US
Mingjie Zhang - Bethesda MD, US
International Classification:
A61K 39/21
C07K 14/005
C12N 15/86
A61K 39/12
C12N 7/00
Abstract:
The present invention discloses the construction of dengue virus subgenomic replicons containing large deletions in the structural region (C-preM-E) of the genome, which replicons are useful as vaccines to protect against dengue virus infection.

Wikipedia References

Mingjie Zhang Photo 2

Mingjie Zhang

Work:
Company:

Hong Kong University of Science and Technology

Position:

Assessor

Education:
Studied at:

Fudan University • University of Calgary

Academic degree:

Professor

Area of science:

Biochemistry

Skills & Activities:
Award:

Prize

Control profile
Mingjie Zhang from Trenton, NJ, age ~47 Get Report